Sysmex (OTCMKTS:SSMXY) Sees Strong Trading Volume – Here’s Why

by · The Cerbat Gem

Sysmex Corporation ADR (OTCMKTS:SSMXY – Get Free Report) shares saw strong trading volume on Wednesday . 342,601 shares were traded during mid-day trading, an increase of 147% from the previous session’s volume of 138,746 shares.The stock last traded at $9.71 and had previously closed at $9.96.

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on the stock. The Goldman Sachs Group raised shares of Sysmex from a “hold” rating to a “buy” rating in a research note on Thursday, October 9th. Zacks Research raised Sysmex from a “strong sell” rating to a “hold” rating in a research report on Thursday, August 14th. One equities research analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy”.

Get Our Latest Stock Report on SSMXY

Sysmex Price Performance

The business has a fifty day moving average of $11.46 and a two-hundred day moving average of $14.20. The company has a debt-to-equity ratio of 0.12, a quick ratio of 2.49 and a current ratio of 3.37. The firm has a market capitalization of $6.17 billion, a price-to-earnings ratio of 19.61 and a beta of 1.16.

Sysmex (OTCMKTS:SSMXY – Get Free Report) last issued its quarterly earnings data on Wednesday, November 5th. The company reported $0.16 earnings per share for the quarter, meeting the consensus estimate of $0.16. Sysmex had a net margin of 9.35% and a return on equity of 10.20%. The company had revenue of $826.60 million for the quarter, compared to analyst estimates of $880.80 million. As a group, research analysts predict that Sysmex Corporation ADR will post 0.57 EPS for the current fiscal year.

Sysmex Company Profile

(Get Free Report)

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.

Further Reading